Mobius Scientific
1 known investors
Mobius Scientific develops treatments for age-related macular degeneration and other retinal diseases by targeting the root cause of vision loss. The company serves patients with progressive vision loss globally.
Investors · 1
Competitors · 2
by search overlap
ProbiusDX7 shared keywordsProbius develops Quantum Electrochemical Spectroscopy (QES), a label- and reagent-free electrochemical sensing technology that detects and quantifies thousands of analytes—proteins, metabolites, and cells—from microliter-scale biological samples in about 30 minutes. The platform generates digital representations of biological specimens and cloud-based multiplex assays intended to feed AI models of biology for biomarker discovery, drug development, and bioproduction quality control.
Mobiamedical3 shared keywordsMobia Medical (formerly MicroTransponder) develops Vivistim Paired VNS Therapy, an FDA-approved vagus nerve stimulation treatment for chronic ischemic stroke survivors with moderate to severe upper extremity impairment. It serves stroke patients and the clinicians who treat them in the medical device industry.
Companies competing with Mobius Scientific for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Mobius Scientific do?
- Mobius Scientific develops treatments for age-related macular degeneration and other retinal diseases by targeting the root cause of vision loss. The company serves patients with progressive vision loss globally.
- Who are Mobius Scientific's investors?
- Mobius Scientific's investors include Lauder Partners.